Full Text View
Tabular View
No Study Results Posted
Related Studies
Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients
This study is currently recruiting participants.
Study NCT00574197   Information provided by Cedars-Sinai Medical Center
First Received: December 13, 2007   Last Updated: August 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastrointestinal Symptoms
Heart Transplantation
Additional conditions recognized in this trial
Gastrointestinal Diseases
Signs and Symptoms, Digestive
More general conditions related to this trial
Digestive System Diseases
Signs and Symptoms
Interventions listed in this trial
Mycophenolate Sodium
Additional drug interventions recognized in this trial
Mycophenolate mofetil
Mycophenolic Acid
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cedars-Sinai Medical Center
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services